Men with BRCA1/2 PV/LPVs should undergo clinical breast examination every 6–12 months, starting at the age of 35, and annual prostate cancer screening, starting at the age of 40 (in particular in BRCA2 PV/LPV carriers) [55]. The gene discussed is BRCA1; the disease is prostate cancer.